Perifosine treatment led to a significant increase in the percentages of SA-β-gal- and SAHF-positive cells (Fig. 6B–E), as well as the protein level of p21, in B7-H3-overexpressing CRC cells treated with low-dose DOX (Fig. 6A). The gene discussed is CD276; the disease is colorectal carcinoma.